Evaluation of Triage Tools in Rheumatology

Conditions

patients with suspicion of inflammatory rheumatic diseases

Johannes Knitza, Koray Taşçılar, Franziska Fuchs, J. F. Mohn, Sebastian Kühn et al. (22 authors)

Journal of Medical Internet Research2024-07-2313 citations

Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial.

Knitza J, Mohn J, Bergmann C, Kampylafka E, Hagen M, Bohr D, Morf H, Araujo E, Englbrecht M, Simon D, Kleyer A, Meinderink T, Vorbrüggen W, von der Decken CB, Kleinert S, Ramming A, Distler JHW, Vuillerme N, Fricker A, Bartz-Bazzanella P, Schett G, Hueber AJ, Welcker M.

2021-04-1349 citations

10.1186/s13075-021-02498-8

Interventions

Group 1: Patient starts with Ada Chatbot and uses Rheport afterwards. Group 2: Patient starts with Rheport first and uses Ada Chatbot afterwards.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients speaking fluently English or German without diagnosis of current symptoms

Exclusion criteria

Exclusion criteria: patients refusing or not being able to participate in study

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of Ada and Rheport concerning inflammatory rheumatic diseases. To evaluate this outcome the diagnosis results of both tools are compared to the final diagnosis of the rheumatologist after the completed visit.	—

Secondary

Measure	Time frame
• Evaluation of suggested next steps • Evaluation of Usability • previous usage of ressources to evaluate symptoms (internet, doctor visits) • time from symptom onset until time seen by a rheumatologist	—

Countries

Germany

Contacts

Public ContactJohannes Knitza

Medizinische Klinik 3, Universitätsklinikum Erlangen

johannes.knitza@uk-erlangen.de+4991318534742

Outcome results

None listed